Hydrate Soft Capsule 0.5mg (Dutasteride)

Adult dose

The recommended dose of this medicine is 1 capsule (0.5mg) once daily. As exposure to the capsule contents may cause irritation of the oropharyngeal mucosa, swallow the capsule whole without chewing or splitting it. This medicine may be taken with or without food. No dose adjustment is necessary in patients with renal impairment or older patients. The recommended dose in patients with hepatic impairment has not been established because there are no data on the use of this medicine in these patients.

This medication may be absorbed through the skin; therefore, women who are pregnant or may become pregnant should not handle this medication. If the capsule is broken and the medication comes into contact with the skin, wash it immediately with soap and water. This medication should not be used by children under 18 years of age, and care should be taken to ensure that children do not come into contact with the medication. Women, individuals under 18, and those allergic to this drug or similar components should not use it. Adult men planning to conceive should use this medication cautiously based on a doctor's judgment, as it may affect reproductive capacity. Patients with urinary problems or severe decrease in urination should be careful when using this medication and should be closely monitored for any signs of urinary retention. Patients with liver dysfunction should also use this medication with caution. Patients taking strong CYP3A4 enzyme inhibitors for an extended period may need to be cautious as this medication's blood concentration may increase. While taking this medication, genital-related side effects such as erectile dysfunction, decreased libido, and ejaculation disorders may occur, and these symptoms may persist even after discontinuation of the medication. This drug is used for the treatment of benign prostatic hyperplasia and male pattern hair loss, but regular PSA tests and digital rectal examinations are necessary to evaluate the risk of prostate cancer. PSA levels may decrease while taking this medication, so initial values need to be reset when interpreting PSA test results. Blood donation should not occur within six months after dosage, and measures should be taken to prevent transfer of this medication to pregnant women. This medication is known not to affect driving or the ability to operate machinery. There is no specific antidote for overdose, so appropriate supportive treatment is necessary based on symptoms, and caution is needed as the half-life of the medication is long. Store out of reach of children and keep in the original container to prevent quality deterioration and misuse.

• Erectile dysfunction
• decreased libido
• ejaculation disorder
• gynecomastia
• headache
• gastrointestinal discomfort and pain
• sexual dysfunction
• breast disorders
• dizziness
• rash

This medication should be stored in a tightly sealed container to prevent air ingress, and it is important to keep the temperature below 30 degrees. This storage method helps maintain the medication's effectiveness for a prolonged period.

Appearance

Yellowish rectangular soft capsule filled with colorless transparent contents

Package unit

30 capsules - 10 capsules/PTP [(10 capsules/PTP packaging x 3)], 90 capsules - 10 capsules/PTP [(10 capsules/PTP packaging x 9)]